Amerijet International Airlines – First U.S. All-Cargo Airline To Earn CEIV Certification

Jul 12, 2017

Fort Lauderdale, FL, July 11th, 2017 – Amerijet International is the first all-cargo airline of U.S. origin to earn IATA’s CEIV-Pharma certification after being awarded the designation on June 27, 2017. Successful completion of the certification process allows Amerijet to strengthen its promise to exceed the high standards set by the pharmaceutical industry. Amerijet has invested heavily in technology, infrastructure and processes over the last few years to ensure the safe handling and transportation of high-value and temperature sensitive cargo. “This certification reconfirms our commitment to offering the highest consistent quality, professionalism and transparency to our customers. Being the first ...

Read More


Jul 5, 2017

All pharmaceutical companies selling drugs in the US must be partially compliant with the FDA serialisation regulations since January 2015. And since the beginning of 2017 all drugs sold in the EU must comply with the EU ‘Falsified Medicines Directive’. These measures will help pharmaceutical companies better identify defective drugs as well as counterfeit pharmaceuticals that pose a serious danger to public health. There are many regions where pharma regulatory systems are weak, due to which, the probability of spurious drugs increases. Globally, the importance of implementing a comprehensive track and trace system is to monitor the entire production and ...

Read More

PCI Pharma Services Hay-on-Wye Announces Significant Expansion in Serialization Technology, with Operational Flexible Serialization Suite

Jul 4, 2017

Philadelphia, PA, 4 July 2017 – Leading outsourcing services provider PCI Pharma Services (PCI) today announced a significant expansion of its market-leading Serialization capability at its Hay-on-Wye site, Wales, UK.  The suite installation increases the site’s Serialization capability to support PCI’s clients in advance of meeting the implementation dates of the European Falsified Medicines Directive (EU FMD).  The highly flexible technology delivers machine and human-readable coding, tamper evident solutions and Bollini labelling – which in turn is linked to a case loading and aggregation station, with a final aggregation station compacting cases to pallet.  PCI is a strong supporter of ...

Read More

Cobra Biologics: Contract Manufacturing Excellence

Jun 28, 2017

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ products through to clinical and commercial manufacture within three GMP approved facilities in the UK and Sweden.   Expertise Cobra is a Contract Development and Manufacturing Organisation (CDMO) supporting the global life sciences industry in the development and manufacture of monoclonal antibodies (mAb), recombinant proteins, DNA, viral vectors, microbiota and cell line derived products and pharmaceuticals for clinical trials and commercial supply. Experience Over 18 years of track record in producing biologics ...

Read More

Container Closure

Jun 13, 2017

As the world of biologics continues to expand, so does the need for innovative combination products. Care is shifting from hospital to home administration, and devices are an integral part of the patient experience. With the patient experience in mind, the 2017 PDA Container Closure, Devices and Delivery Systems: Compatibility and Material Safety Workshop will focus on the most current and relevant topics in the world of container closure for device and delivery systems as they relate to material compatibility and safety. At this Workshop, hear about biocompatibility testing, future directions for combination products and more. Register now! At ...

Read More